Clinical Trial Update: The Post-Vitrectomy Lenstatin™ Study [NA]

View source ↗

Summary

The post-vitrectomy Lenstatin study for nuclear cataract has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Nuclear Cataract

Drugs mentioned

• Lenstatin (Lenstatin)

Snippet

Sponsor: Lenstatin LLC | Conditions: Cataract, Nuclear Progressive | NA | Status: COMPLETED